Novel imidazopyridine suppresses STAT3 activation by targeting SHP-1

about

Novel imidazopyridine suppresses STAT3 activation by targeting SHP-1

Item

http://www.wikidata.org/entity/Q59126618

description

scientific article published on 01 December 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в грудні 2018

@uk

name

Novel imidazopyridine suppresses STAT3 activation by targeting SHP-1

@en

Novel imidazopyridine suppresses STAT3 activation by targeting SHP-1

@nl

type

Item

label

Novel imidazopyridine suppresses STAT3 activation by targeting SHP-1

@en

Novel imidazopyridine suppresses STAT3 activation by targeting SHP-1

@nl

prefLabel

Novel imidazopyridine suppresses STAT3 activation by targeting SHP-1

@en

Novel imidazopyridine suppresses STAT3 activation by targeting SHP-1

@nl

P1476

Novel imidazopyridine suppresses STAT3 activation by targeting SHP-1

@en

P2093

Chuan-Hsun Chang

http://www.w3.org/2001/XMLSchema#string

Chung-Wai Shiau

http://www.w3.org/2001/XMLSchema#string

Jung-Chen Su

http://www.w3.org/2001/XMLSchema#string

P2860

Toll-like receptor 4 variant D299G induces features of neoplastic progression in Caco-2 intestinal cells and is associated with advanced human colon cancer

Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6

A phase I/II study of the pan Bcl-2 inhibitor obatoclax mesylate plus bortezomib for relapsed or refractory mantle cell lymphoma.

Alteration of SHP-1/p-STAT3 Signaling: A Potential Target for Anticancer Therapy.

STAT3-induced S1PR1 expression is crucial for persistent STAT3 activation in tumors.

Obatoclax and lapatinib interact to induce toxic autophagy through NOXA.

Small molecule obatoclax (GX15-070) antagonizes MCL-1 and overcomes MCL-1-mediated resistance to apoptosis.

G-protein-coupled receptor agonist BV8/prokineticin-2 and STAT3 protein form a feed-forward loop in both normal and malignant myeloid cells.

Disrupting VEGF-A paracrine and autocrine loops by targeting SHP-1 suppresses triple negative breast cancer metastasis.

Protein tyrosine phosphatases: regulatory mechanisms.

P304

1248-1255

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/14756366.2018.1497019

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Szu-Hsien Wu

P577

2018-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30261753

http://www.w3.org/2001/XMLSchema#string

P921

drug discovery

P932

6161598

http://www.w3.org/2001/XMLSchema#string